Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • COMMENT

eTRANSAFE: data science to empower translational safety assessment

Thirteen pharmaceutical companies have shared and integrated preclinical and clinical data for creating computational resources that enhance translational drug safety assessment.
  1. Ferran Sanz

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. François Pognan

    1. Novartis Pharma, Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  3. Thomas Steger-Hartmann

    1. Bayer, Berlin, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  4. Carlos Díaz

    1. Synapse Research Management Partners, Madrid, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  5. Shoji Asakura

    1. Eisai, Tsukuba, Ibaraki, Japan.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  6. Alexander Amberg

    1. Preclinical Safety, Sanofi, Frankfurt am Main, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  7. Nathalie Bécourt-Lhote

    1. Non-Clinical Drug Safety, Translational Medicine, Servier, Suresnes, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  8. Niklas Blomberg

    1. ELIXIR, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  9. Nicolas Bosc

    1. European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  10. Katharine Briggs

    1. Lhasa Limited, Leeds, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  11. Frank Bringezu

    1. Chemical and Preclinical Safety, Merck Healthcare KGaA, Darmstadt, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  12. Claire Brulle-Wohlhueter

    1. Translational and Genomic Medicine Safety, Sanofi, 91380 Chilly-Mazarin, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  13. Søren Brunak

    1. Technical University of Denmark (DTU), Lyngby, Denmark; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Present address: Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  14. Ruud Bueters

    1. Janssen Research & Development, Janssen Pharmaceutica, Beerse, Belgium.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  15. Giulia Callegaro

    1. Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  16. Salvador Capella-Gutierrez

    1. Barcelona Supercomputing Center (BSC), Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  17. Emilio Centeno

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  18. Javier Corvi

    1. Barcelona Supercomputing Center (BSC), Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  19. Mark T. D. Cronin

    1. Liverpool John Moores University, Liverpool, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  20. Philip Drew

    1. PDS Consultants, Leicester, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  21. Guillemette Duchateau-Nguyen

    1. Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  22. Gerhard F. Ecker

    1. Universität Wien, Vienna, Austria.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  23. Sylvia Escher

    1. Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  24. Eloy Felix

    1. European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  25. Miguel Ferreiro

    1. GMV, Tres Cantos, Madrid, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  26. Markus Frericks

    1. BASF, Ludwigshafen, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  27. Laura I. Furlong

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain; MedBioinformatics Solutions, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  28. Robert Geiger

    1. BASF, Ludwigshafen, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  29. Catherine George

    1. Ipsen Innovation, Les Ulis, France.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  30. Melanie Grandits

    1. Universität Wien, Vienna, Austria.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  31. Dragomir Ivanov-Draganov

    1. Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  32. Jean Kilgour-Christie

    1. Novartis Pharma, Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  33. Tevfik Kiziloren

    1. European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  34. Jan A. Kors

    1. Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  35. Naoki Koyama

    1. Eisai, Tsukuba, Ibaraki, Japan.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  36. Annika Kreuchwig

    1. Bayer, Berlin, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  37. Andrew R. Leach

    1. European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  38. Miguel-Angel Mayer

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  39. Peter Monecke

    1. Preclinical Safety, Sanofi, Frankfurt am Main, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  40. Wolfgang Muster

    1. Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  41. Chihiro Miyamoto Nakazawa

    1. Eisai, Tsukuba, Ibaraki, Japan.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  42. Gavin Nicholson

    1. Optibrium Ltd., Cambridge Innovation Park, Cambridge, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  43. Rowan Parry

    1. Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  44. Manuel Pastor

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  45. Janet Piñero

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain; MedBioinformatics Solutions, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  46. Nils Oberhauser

    1. Novartis Pharma, Basel, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  47. Juan Manuel Ramírez-Anguita

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  48. Adrián Rodrigo

    1. GMV, Tres Cantos, Madrid, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  49. Aljosa Smajic

    1. Universität Wien, Vienna, Austria.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  50. Markus Schaefer

    1. Preclinical Safety, Sanofi, Frankfurt am Main, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  51. Sebastian Schieferdecker

    1. Boehringer Ingelheim Pharma, Biberach an der Riss, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  52. Inari Soininen

    1. Synapse Research Management Partners, Madrid, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  53. Emma Terricabras

    1. Hospital del Mar Research Institute (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  54. Panuwat Trairatphisan

    1. AbbVie Germany, Ludwigshafen am Rhein, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  55. Sean C. Turner

    1. AbbVie Germany, Ludwigshafen am Rhein, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  56. Alfonso Valencia

    1. Barcelona Supercomputing Center (BSC), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  57. Bob van de Water

    1. Leiden Academic Centre for Drug Research (LACDR), Leiden University, Leiden, The Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  58. Johan L. van der Lei

    1. Synapse Research Management Partners, Madrid, Spain; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  59. Erik M. van Mulligen

    1. Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  60. Esther Vock

    1. Boehringer Ingelheim Pharma, Biberach an der Riss, Germany.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  61. David Wilkinson

    1. Lhasa Limited, Leeds, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Drug research and development (R&D) is knowledge-intensive, and so can benefit from advances in data science and technologies, such as automated data curation, data integration and artificial intelligence. Data sharing beyond the boundaries of individual pharmaceutical companies offers particularly interesting opportunities for accelerating and improving aspects of the R&D process. However, balancing collaboration and confidentiality remains a complex challenge for the industry.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 22, 605-606 (2023)

doi: https://doi.org/10.1038/d41573-023-00099-5

References

  1. Pognan, F. et al. The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives. Pharmaceuticals (Basel). 14, 237 (2021).

    Article  PubMed  Google Scholar 

  2. Piñero, J. et al. Genomic and proteomic biomarker landscape in clinical trials. Comput. Struct. Biotechnol. J. 21, 2110–2118 (2023).

    Article  PubMed  Google Scholar 

  3. Callegaro, G. et al. The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment. Arch. Toxicol. 95, 3745–3775 (2021).

    Article  PubMed  Google Scholar 

  4. Pastor, M., Gómez-Tamayo, J. C. & Sanz, F. Flame: an open-source framework for model development, hosting, and usage in production environments. J. Cheminform. 13, 31 (2021).

    Article  PubMed  Google Scholar 

  5. Steger-Hartmann, T. et al. Perspectives of data science in preclinical safety assessment. Drug Discov. Today 28, 103642 (2023).

    Article  PubMed  Google Scholar 

  6. Clark, M. & Steger-Hartmann, T. A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans. Regul. Toxicol. Pharmacol. 96, 94–105 (2018).

    Article  PubMed  Google Scholar 

  7. Steger-Hartmann, T. et al. Introducing the concept of virtual control groups into preclinical toxicology testing. ALTEX 37, 343–349 (2020).

    PubMed  Google Scholar 

Download references

Competing Interests

Some authors are employed in the pharmaceutical industry or in small-and-medium sized enterprises, as indicated in their affiliations. The other authors declare no competing interests.

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links